Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.8M Buy
208,978
+106,860
+105% +$11.5M 0.02% 900
2026
Q1
$10.5M Buy
+102,118
New +$10.4M 0.01% 1377
2025
Q3
Sell
-8,959
Closed -$684K 3835
2025
Q2
$684K Sell
8,959
-150,164
-94% -$11M ﹤0.01% 2447
2025
Q1
$11.3M Sell
159,123
-54,759
-26% -$4.28M 0.02% 721
2024
Q4
$16.7M Sell
213,882
-48,506
-18% -$4.53M 0.04% 541
2024
Q3
$26.8M Sell
262,388
-20,274
-7% -$1.68M 0.06% 394
2024
Q2
$21.4M Buy
282,662
+248,913
+738% +$17.7M 0.05% 433
2024
Q1
$2.53M Buy
33,749
+18,649
+124% +$1.48M 0.01% 1324
2023
Q4
$1.11M Hold
15,100
﹤0.01% 2008
2023
Q3
$694K Hold
15,100
﹤0.01% 2132
2023
Q2
$637K Buy
15,100
+2,000
+15% +$75.6K ﹤0.01% 2212
2023
Q1
$342K Sell
13,100
-13,632
-51% -$403K ﹤0.01% 2363
2022
Q4
$796K Buy
+26,732
New +$746K ﹤0.01% 1820

Other funds holding NUVL

John Overdeck's NUVL Position: Q2 2026 in Review

John Overdeck increased its Nuvalent (NUVL) stake by 105% in Q2 2026, buying an estimated $11.5M and bringing the position to 208,978 shares worth $25.8M. The position accounts for 0.02% of the portfolio, ranked #900.

John Overdeck first reported a position in NUVL in Q4 2022 and has held it in 13 quarters since. The position peaked at $26.8M in Q3 2024. 287 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • John Overdeck held 208,978 shares of Nuvalent worth $25.8M as of Q2 2026.
  • John Overdeck bought 106,860 Nuvalent shares in Q2 2026, an estimated $11.5M.
  • Nuvalent made up 0.02% of John Overdeck's portfolio in Q2 2026, its #900 holding.
  • John Overdeck first reported a position in Nuvalent in Q4 2022 and has held it in 13 quarters since.
  • John Overdeck's Nuvalent position peaked at $26.8M in Q3 2024.
  • 287 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.